^
CANCER:

Anaplastic Astrocytoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Anaplastic Astrocytoma
temozolomide
Sensitive
:
A1
No biomarker
Anaplastic Astrocytoma
PCV
Sensitive
:
A2
IDH1 R132H
Anaplastic Astrocytoma
temozolomide
Sensitive
:
B
MGMT promoter methylation
Anaplastic Astrocytoma
temozolomide
Sensitive
:
B
BRAF V600
Anaplastic Astrocytoma
vemurafenib
Sensitive
:
C1
NRAS mutation
Anaplastic Astrocytoma
atezolizumab + cobimetinib
Sensitive
:
C3
IDH2 mutation
Anaplastic Astrocytoma
PCV
Sensitive
:
C3
IDH1 mutation
Anaplastic Astrocytoma
PCV
Sensitive
:
C3
ABCB1 G412G
Anaplastic Astrocytoma
temozolomide
Sensitive
:
C3
TMB-H
Anaplastic Astrocytoma
nivolumab
Sensitive
:
C3
NACC2-NTRK2 fusion
Anaplastic Astrocytoma
larotrectinib
Sensitive
:
C4
IDH1 R132S + H3K27me3 loss + MET exon 14 skipping mutation
Anaplastic Astrocytoma
carboplatin + temozolomide + vincristine
Resistant
:
C4
BRAF mutation
Anaplastic Astrocytoma
dabrafenib
Sensitive
:
C4